These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 7707431)

  • 1. Issues remain for treating colorectal cancer.
    Reynolds T
    J Natl Cancer Inst; 1995 Apr; 87(7):480. PubMed ID: 7707431
    [No Abstract]   [Full Text] [Related]  

  • 2. Treating rectal cancer: key issues reconsidered.
    Fakih M
    Oncology (Williston Park); 2008 Nov; 22(12):1444-6. PubMed ID: 19322952
    [No Abstract]   [Full Text] [Related]  

  • 3. Unraveling the Complexities of Treating Metastatic Colorectal Cancer With Angiogenesis Inhibitors.
    Overstreet K; Van Cutsem E; Johnson M
    Clin Colorectal Cancer; 2015 Sep; 14(3):131-2. PubMed ID: 26089238
    [No Abstract]   [Full Text] [Related]  

  • 4. Novel therapeutic strategies for colorectal cancer.
    Kerr DJ; Ferry DR
    Hosp Med; 1998 Aug; 59(8):617-21. PubMed ID: 9829054
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Issues of molecular targeted therapies in combination with chemotherapy in metastatic colorectal cancer].
    Asayama M; Kadowaki S; Yamaguchi K
    Nihon Rinsho; 2011 Apr; 69 Suppl 3():464-71. PubMed ID: 22214005
    [No Abstract]   [Full Text] [Related]  

  • 6. The role of cetuximab in the treatment of metastatic colorectal cancer.
    Holubec L; Liska V; Matejka VM; Fiala O; Dreslerova J; Mrazkova P; Treska V; Finek J
    Anticancer Res; 2012 Sep; 32(9):4007-11. PubMed ID: 22993351
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bevacizumab and cetuximab for colorectal cancer.
    Drug Ther Bull; 2006 May; 44(5):37-40. PubMed ID: 16706233
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Capecitabine in the treatment of colorectal cancer.
    Kelly C; Cassidy J
    Expert Rev Anticancer Ther; 2007 Jun; 7(6):803-10. PubMed ID: 17555390
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Questionnaire survey on patients receiving scheduled inpatient chemotherapy clarifies the issues of outpatient chemotherapy for advanced or recurrent colorectal cancer].
    Arakawa Y; Sakuyama T; Ichiba T; Inoue D; Kobayashi T; Aiba K
    Gan To Kagaku Ryoho; 2007 Dec; 34 Suppl 2():245-7. PubMed ID: 20443276
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Gastrointestinal surgeons should master the adjuvant therapy of colorectal cancer].
    Gu J; Chen P
    Zhonghua Wei Chang Wai Ke Za Zhi; 2015 Oct; 18(10):974-8. PubMed ID: 26499138
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [First/second/third-line chemotherapy with molecular targeted drugs for colorectal cancer].
    Sato A; Nakamachi M; Imataka H
    Gan To Kagaku Ryoho; 2009 Aug; 36(8):1242-6. PubMed ID: 19692761
    [TBL] [Abstract][Full Text] [Related]  

  • 12. First-line capecitabine is as effective as 5-fluorouracil/leucovorin in treating advanced colorectal cancer.
    Gambill BD
    Clin Colorectal Cancer; 2001 May; 1(1):18-9. PubMed ID: 12445375
    [No Abstract]   [Full Text] [Related]  

  • 13. Capecitabine/irinotecan combination regimens in colorectal cancer.
    Kerr DJ
    Oncology (Williston Park); 2002 Apr; 16(4 Suppl 3):27-9. PubMed ID: 12014865
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Advances in the treatment of colorectal cancer].
    Maehara Y; Ohno S; Tomisaki S; Kakeji Y; Watanabe A; Baba H; Adachi Y; Ichiyoshi Y; Korenaga D; Sugimachi K
    Gan To Kagaku Ryoho; 1996 Apr; 23(5):517-28. PubMed ID: 8678508
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predicting the outcome of chemotherapy for colorectal cancer.
    Allen WL; Coyle VM; Johnston PG
    Curr Opin Pharmacol; 2006 Aug; 6(4):332-6. PubMed ID: 16750422
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnosis and management of DNA mismatch repair-deficient colorectal cancer.
    Stadler ZK
    Hematol Oncol Clin North Am; 2015 Feb; 29(1):29-41. PubMed ID: 25475571
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Peri-operative chemotherapy for resectable colorectal cancer liver metastases].
    Kanemitsu Y; Shida D; Tsukamoto S; Ochiai H
    Nihon Rinsho; 2016 Nov; 74(11):1863-1871. PubMed ID: 30550696
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nivolumab for the treatment of colorectal cancer.
    Smith KM; Desai J
    Expert Rev Anticancer Ther; 2018 Jul; 18(7):611-618. PubMed ID: 29792730
    [TBL] [Abstract][Full Text] [Related]  

  • 19. COX-2 inhibitors: a potential target for drug therapy in the management of colorectal cancer.
    Ryan AR; Rosita AR; Kamarul AK; Qureshi A
    Med J Malaysia; 1999 Sep; 54(3):293-5. PubMed ID: 11045053
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic strategies for colorectal cancer in Europe and the United States: focus on chemotherapy for advanced colorectal cancer.
    Bennouna J; Douillard JY
    Int J Clin Oncol; 2002 Aug; 7(4):236-44. PubMed ID: 12202977
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.